158 related articles for article (PubMed ID: 1369829)
21. Continuous intravenous administration of rmGM-CSF enhances immune as well as hematopoietic reconstitution following syngeneic bone marrow transplantation in mice.
Naparstek E; Ohana M; Greenberger JS; Slavin S
Exp Hematol; 1993 Jan; 21(1):131-7. PubMed ID: 8417949
[TBL] [Abstract][Full Text] [Related]
22. Hematopoietic recovery following high-dose combined alkylating-agent chemotherapy and autologous bone marrow support in patients in phase-I clinical trials of colony-stimulating factors: G-CSF, GM-CSF, IL-1, IL-2, M-CSF.
Laughlin MJ; Kirkpatrick G; Sabiston N; Peters W; Kurtzberg J
Ann Hematol; 1993 Dec; 67(6):267-76. PubMed ID: 7506580
[TBL] [Abstract][Full Text] [Related]
23. Granulocyte colony-stimulating factor (CSF) but not interleukin-1 (IL-1), IL-3, and granulocyte-macrophage CSF protect bone marrow progenitor cells from suppression by allosensitized cytotoxic T cells.
Gerritsen WR; O'Reilly RJ
Blood; 1994 Sep; 84(6):1906-12. PubMed ID: 7521693
[TBL] [Abstract][Full Text] [Related]
24. Enhancement of the grafting efficiency of transplanted marrow cells by preincubation with interleukin-3 and granulocyte-macrophage colony-stimulating factor.
Tavassoli M; Konno M; Shiota Y; Omoto E; Minguell JJ; Zanjani ED
Blood; 1991 Apr; 77(7):1599-606. PubMed ID: 2009376
[TBL] [Abstract][Full Text] [Related]
25. Synergy of interleukin 1 and granulocyte colony-stimulating factor: in vivo stimulation of stem-cell recovery and hematopoietic regeneration following 5-fluorouracil treatment of mice.
Moore MA; Warren DJ
Proc Natl Acad Sci U S A; 1987 Oct; 84(20):7134-8. PubMed ID: 3499607
[TBL] [Abstract][Full Text] [Related]
26. Interleukin-2-activated natural killer cells can support hematopoiesis in vitro and promote marrow engraftment in vivo.
Murphy WJ; Keller JR; Harrison CL; Young HA; Longo DL
Blood; 1992 Aug; 80(3):670-7. PubMed ID: 1379086
[TBL] [Abstract][Full Text] [Related]
27. Effect of interleukin-4 on the growth of granulocyte-macrophage progenitor cells stimulated by hematopoietic growth factors.
Sato T; Misago M; Tsukada J; Kikuchi M; Oda S; Chiba S; Eto S
J UOEH; 1990 Jun; 12(2):163-74. PubMed ID: 1697091
[TBL] [Abstract][Full Text] [Related]
28. Synergy between recombinant human IL-1 alpha (rHuIL-1) and M-CSF (rHuM-CSF) during the recovery of murine hematopoietic activity in myelosuppressed animals: abbreviated versus chronic administration of rHuM-CSF.
Kovacs CJ; Harrell JP; Gooya JM; Evans MJ; Johnke RM
Exp Hematol; 1992 Jun; 20(5):582-9. PubMed ID: 1587305
[TBL] [Abstract][Full Text] [Related]
29. Protection from lethal murine graft-versus-host disease without compromise of alloengraftment using transgenic donor T cells expressing a thymidine kinase suicide gene.
Drobyski WR; Morse HC; Burns WH; Casper JT; Sandford G
Blood; 2001 Apr; 97(8):2506-13. PubMed ID: 11290616
[TBL] [Abstract][Full Text] [Related]
30. Immunologic and hematopoietic effects of CD40 stimulation after syngeneic bone marrow transplantation in mice.
Funakoshi S; Taub DD; Anver MR; Raziuddin A; Asai O; Reddy V; Rager H; Fanslow WC; Longo DL; Murphy WJ
J Clin Invest; 1997 Feb; 99(3):484-91. PubMed ID: 9022082
[TBL] [Abstract][Full Text] [Related]
31. Stem cell responses in myelosuppressed mice following sequential treatment with recombinant human interleukin 1 (rHuIL-1), recombinant murine interleukin 3 (rMuIL-3) and recombinant human macrophage colony-stimulating factor (rHuM-CSF).
Kovacs CJ; Harrell JP; Evans MJ; Abernathy RS; Roberts CJ; Johnke RM
Stem Cells; 1994 Jan; 12(1):103-13. PubMed ID: 8142915
[TBL] [Abstract][Full Text] [Related]
32. Administration of granulocyte colony-stimulating factor to recipients followed by intra-bone marrow-bone marrow transplantation accelerates acceptance of allogeneic bone marrow cells in mice.
Suzuki Y; Adachi Y; Zhang Y; Minamino K; Iwasaki M; Mukaide H; Shi M; Nakano K; Koike Y; Wang J; Koike-Kiriyama N; Shigematsu A; Yanai S; Ikehara S
Immunobiology; 2008; 213(5):427-35. PubMed ID: 18472051
[TBL] [Abstract][Full Text] [Related]
33. Enhanced survival but reduced engraftment in murine recipients of recombinant granulocyte/macrophage colony-stimulating factor following transplantation of T-cell-depleted histoincompatible bone marrow.
Blazar BR; Widmer MB; Soderling CC; Gillis S; Vallera DA
Blood; 1988 Oct; 72(4):1148-54. PubMed ID: 3048434
[TBL] [Abstract][Full Text] [Related]
34. Rapamycin, a potent inhibitor of T-cell function, prevents graft rejection in murine recipients of allogeneic T-cell-depleted donor marrow.
Blazar BR; Taylor PA; Sehgal SN; Vallera DA
Blood; 1994 Jan; 83(2):600-9. PubMed ID: 8286755
[TBL] [Abstract][Full Text] [Related]
35. A critical role for CD48 antigen in regulating alloengraftment and lymphohematopoietic recovery after bone marrow transplantation.
Blazar BR; Taylor PA; Panoskaltsis-Mortari A; Yagita H; Bromberg JS; Vallera DA
Blood; 1998 Dec; 92(11):4453-63. PubMed ID: 9834253
[TBL] [Abstract][Full Text] [Related]
36. Improved survival and leukocyte reconstitution without detrimental effects on engraftment in murine recipients of human recombinant granulocyte colony-stimulating factor after transplantation of T-cell-depleted histoincompatible bone marrow.
Blazar BR; Widmer MB; Cosman D; Sassenfeld HM; Vallera DA
Blood; 1989 Nov; 74(6):2264-9. PubMed ID: 2478225
[TBL] [Abstract][Full Text] [Related]
37. The use of recombinant cytokines for enhancing immunohematopoietic reconstitution following bone marrow transplantation. II. The influence of lymphokines on CFU-GM colonies from human untreated, ASTA-Z or Campath-1M treated bone marrow.
Mumcuoglu M; Naparstek E; Slavin S
Bone Marrow Transplant; 1990 Mar; 5(3):153-8. PubMed ID: 2184907
[TBL] [Abstract][Full Text] [Related]
38. Modulation of murine hematopoiesis in vivo with recombinant murine interleukin-1.
Gallicchio VS; Shedlofsky SI; Swim AT; Robinson JM; Hulette BC; Messino MJ; Doukas MA
J Biol Response Mod; 1989 Aug; 8(4):422-39. PubMed ID: 2666587
[TBL] [Abstract][Full Text] [Related]
39. Lack of correlation between an assay used to determine early marrow allograft rejection and long-term chimerism after murine allogeneic bone marrow transplantation: effects of marrow dose.
Koh CY; Welniak LA; Murphy WJ
Biol Blood Marrow Transplant; 2005 Apr; 11(4):252-9. PubMed ID: 15812390
[TBL] [Abstract][Full Text] [Related]
40. Effects of interleukin-6 on hematopoiesis in allogeneic and syngeneic bone marrow chimeras.
Imamura M; Han M; Hashino S; Kobayashi H; Imai K; Kobayashi M; Kobayashi S; Tanaka J; Kasai M; Sakurada K
Immunobiology; 1994 Aug; 191(1):21-37. PubMed ID: 7806257
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
